Related Experiment Video
Updated: Aug 5, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Calcium dependent conformational changes in human transglutaminase 2 and its implications in celiac disease
Srimari Srikanth1, Pavinap Priyaa Karthikeyan2, Mezya Sezen2
1School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi, Delhi, 110067, India; Molecular Motors Lab, Department of Biotechnology, School of Chemical & Biotechnology, SASTRA Deemed to be University, Tirumalaisamudram, Thanjavur, Tamil Nadu, 613401, India.
Abstract:
Transglutaminase 2 (TG2) serves as a modifiable transamidating acyltransferase that precipitates calcium-induced protein alterations. The enzyme plays a crucial role in the cell and disease states, such as tissue repair, calcium signal transduction, celiac disease, and cancer. It is implicated in protein crosslinking and has been found in high concentrations in the small intestines of those with celiac disease. The function of TG2 hinges upon calcium ions binding to particular sites on the enzyme. In this study, we delve into the contribution of calcium-responsive transglutaminase 2 (TG2) in celiac disease, utilizing both molecular dynamics simulations and coarse-grained models, and investigate the impact of non-synonymous single nucleotide polymorphisms (nsSNPs) on TG2. Molecular dynamics reveal prominent conformational differences between the open and closed conformations. In the coarse-grained model, key residues are found adjacent to the active site in the open conformation, while in the closed conformation, key residues are distant from the active site. We further explore the functional impact of nsSNPs in TG2 using both sequence-based and structure-based computational tools. Through a consensus approach, we identify ten nsSNPs that are predicted to destabilize TG2 or alter its structural flexibility, with mutations such as R48H, E186Q, C277S, and E549G likely to influence active site accessibility and calcium coordination. The findings from this research enhance our understanding of the molecular processes underpinning celiac disease and helps facilitate innovative treatment approaches that target calcium-responsive TG2.
Insights
Calcium-responsive transglutaminase 2 (TG2) is key in celiac disease. This study reveals how TG2 mutations impact its structure and function, offering insights for targeted therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Computational Biology
Background:
- Transglutaminase 2 (TG2) is an enzyme involved in calcium-induced protein modifications.
- TG2 plays critical roles in cellular functions and diseases, including celiac disease, cancer, and tissue repair.
- Altered TG2 function and high concentrations in the small intestine are linked to celiac disease pathogenesis.
Purpose of the Study:
- To investigate the role of calcium-responsive TG2 in celiac disease.
- To analyze the structural and functional impact of TG2 non-synonymous single nucleotide polymorphisms (nsSNPs).
Main Methods:
- Utilized molecular dynamics simulations and coarse-grained models to study TG2.
- Employed sequence-based and structure-based computational tools to assess nsSNP effects.
- Applied a consensus approach to identify critical nsSNPs.
Main Results:
- Identified significant conformational differences between open and closed TG2 states.
- Key residues were found near the active site in the open conformation and distant in the closed conformation.
- Ten nsSNPs predicted to destabilize TG2 or alter its flexibility were identified, with specific mutations impacting active site accessibility and calcium binding.
Conclusions:
- Findings enhance understanding of TG2's molecular mechanisms in celiac disease.
- Identified nsSNPs provide insights into TG2 dysfunction in celiac disease.
- This research facilitates the development of novel therapeutic strategies targeting calcium-responsive TG2.
Related Concept Videos
Protein Folding Quality Check in the RER
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Inflammatory Bowel Disease III: Crohn's Disease
